Arnm que codifica el dominio n-terminal y el dominio union al receptor la glicoproteina la espicula sars-cov
Mnexspike Dispersion Inyectable en Jeringa Precargada
In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
Packs
| Pack | Code | Status |
|---|---|---|
| MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,2 ml | 770247 | |
| MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas precargadas de 0,2 ml | 770249 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Arnm que codifica el dominio n-terminal y el dominio union al receptor la glicoproteina la espicula sars-cov
- Strength
- 0,05 mg/ml
- Dosage form
- dispersion inyectable en jeringa precargada
- Route
- vía intramuscular
- Register
- Spain (AEMPS)
- Status
- Authorised
- Status in the register
- Autorizado, no comercializado
- Authorised
- 8 Apr 2026
- Registration
- 1252010004
- Marketing authorisation holder
- Moderna Biotech Spain S.L.
- Procedure
- EU centralised
- Supply
- Medicamento Sujeto A Prescripción Médica
- EU number
- EU/1/25/2010